CONVERTIBLE DEBT ARRANGEMENTS (Details Narrative) - USD ($)				3 Months Ended	6 Months Ended		12 Months Ended
	May 04, 2021	Apr. 06, 2021	Apr. 06, 2021	Dec. 31, 2021	Dec. 31, 2021	Dec. 31, 2020	Jun. 30, 2021
Defined Benefit Plan Disclosure [Line Items]
Convertible notes payable				$ 4,832,616	$ 4,832,616		$ 5,143,795
Debt conversion, shares issued					2,500,000	16,331,766
Debt instrument, convertible, conversion price	$ 0.20
Aggregate amount of common stock issued to purchase warrants				30,000	$ 30,000		63,700
Debt instrument, interest rate, stated percentage	5.00%
Debt instrument description	May 4, 2022 and June 30, 2022, bear interest at the rate of 5% per annum and are convertible at any time upon the option of the Investors into shares of Common Stock at a conversion price equal to $0.20 per share. The Company has the right to prepay all or any portion of the outstanding balance of the Notes in an amount equal to 115% or 120%, depending on whether such repayment is made before November 5, 2021 or after November 5, 2021, respectively, multiplied by the portion of the outstanding balance to be prepaid	upon the occurrence and during the continuance of an Event of Default (as defined in the Note), if lower, at a conversion price equal to 75% of the lowest daily volume-weighted average price (“VWAP”) of the Common Stock during the 20 consecutive trading days immediately preceding the applicable conversion date. The Company has the right to prepay all or any portion of the outstanding balance of the Note in an amount equal to 115% or 120%, depending on whether such repayment is made before or after November 5, 2021, multiplied by the portion of the outstanding balance to be prepaid
Debt converted into shares, amount					500,000	$ 288,182
Debt discount				$ 1,304,993	1,304,993		3,157,759
Amortization of original issue discount, deferred financing costs, and debt discount					2,077,049	494,184
Evergreen Capital Management LLC [Member] | Convertible Debt [Member]
Defined Benefit Plan Disclosure [Line Items]
Debt conversion, shares issued				2,500,000
Debt converted into shares, amount				$ 500,000
Evergreen Agreement [Member] | Convertible Debt [Member]
Defined Benefit Plan Disclosure [Line Items]
Convertible notes payable				166,625	166,625
Evergreen Agreement [Member] | Accredited Investor Eleven [Member] | Evergreen Capital Management LLC [Member]
Defined Benefit Plan Disclosure [Line Items]
Debt instrument, convertible, conversion price		$ 0.20	$ 0.20
Aggregate amount of common stock issued to purchase warrants		$ 2,040,000	$ 2,040,000
Number of common stock issued to purchase warrants		11,730,000	11,730,000
Debt principal amount				1,927,988	1,927,988
Debt Instrument, Maturity Date, Description		April 6, 2022 and May 3, 2022
Debt instrument, interest rate, stated percentage		5.00%	5.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 0.20	$ 0.20
Warrants exercisable terms, description			The Investor will not have the right to exercise the Warrants if the Investor, together with its affiliates, would beneficially own in excess of 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to its conversion and under no circumstances may exercise the Warrants if the Investor, together with its affiliates, would beneficially own in excess of 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to its exercise
Debt original issued discount			$ 306,000
Deferred financing cost		$ 42,500	42,500	1,387,297	1,387,297
Evergreen Agreement [Member] | Accredited Investor Eleven [Member] | Evergreen Capital Management LLC [Member] | First Tranche [Member]
Defined Benefit Plan Disclosure [Line Items]
Aggregate amount of common stock issued to purchase warrants		$ 1,540,000	$ 1,540,000
Number of common stock issued to purchase warrants		8,855,000	8,855,000
Debt principal amount		$ 1,771,000	$ 1,771,000
Evergreen Agreement [Member] | Accredited Investor Eleven [Member] | Evergreen Capital Management LLC [Member] | Second Tranche [Member]
Defined Benefit Plan Disclosure [Line Items]
Aggregate amount of common stock issued to purchase warrants		$ 500,000	$ 500,000
Number of common stock issued to purchase warrants		2,875,000	2,875,000
Debt principal amount		$ 575,000	$ 575,000
Investors Agreement [Member] | Convertible Debt [Member]
Defined Benefit Plan Disclosure [Line Items]
Convertible notes payable				3,075,146	3,075,146
Accrued interest				3,075,146	3,075,146
Deferred financing cost				2,135,337	2,135,337
Investors Agreement [Member] | Accredited Investor Twelve [Member]
Defined Benefit Plan Disclosure [Line Items]
Aggregate amount of common stock issued to purchase warrants	$ 2,550,000
Number of common stock issued to purchase warrants	15,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.20
Debt original issued discount	$ 447,237
Deferred financing cost	10,000
Investors Agreement [Member] | Accredited Investor Twelve [Member] | First Tranche [Member]
Defined Benefit Plan Disclosure [Line Items]
Aggregate amount of common stock issued to purchase warrants	$ 1,924,999
Number of common stock issued to purchase warrants	11,323,529
Debt principal amount	$ 2,264,706
Investors Agreement [Member] | Accredited Investor Twelve [Member] | Second Tranche [Member]
Defined Benefit Plan Disclosure [Line Items]
Aggregate amount of common stock issued to purchase warrants	$ 625,001
Number of common stock issued to purchase warrants	3,676,471
Debt principal amount	$ 735,294
Securities Purchase Agreement [Member]
Defined Benefit Plan Disclosure [Line Items]
Convertible notes payable				$ 303,207	$ 303,207		162,271
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 0.35	$ 0.35
JMJ Financial [Member]
Defined Benefit Plan Disclosure [Line Items]
Convertible notes payable				$ 235,925	$ 235,925		$ 213,545
Accrued interest				$ 9,221	$ 9,221	$ 8,514
Debt conversion, shares issued					11,796		10,677
Debt instrument, convertible, conversion price				$ 20	$ 20		$ 20